patient characteristics | |||
---|---|---|---|
[n] | [%] | ||
patient number | 33 | 100 | |
gender | female | 10 | 30.3 |
male | 23 | 69.7 | |
age at RT | [years] | ||
median | 42 | ||
range | 7-77 | ||
[n] | [%] | ||
pediatric patients [≤ 18 years] | 3 | 9.1 | |
histology | glioma | 26 | 100 |
WHO ° II | 5 | 19.2 | |
WHO ° III | 3 | 11.5 | |
WHO ° IV | 18 | 69.2 | |
meningioma | 7 | 100 | |
WHO ° I | 3 | 43 | |
WHO ° II | 3 | 43 | |
WHO ° III | 1 | 14 | |
radiotherapy | mixed modality | 22 | 66.6 |
[12C] only | 6 | 18.2 | |
[1H] only | 5 | 15.2 | |
particle reirradiation | 7 | 21.2 | |
[ml] | |||
mean particle volume [particle only, ml] | 65.64 | ||
mean particle volume [particle boost, ml] | 69.29 | ||
mean photon volume [particle boost, ml] | 252.65 | ||
[Gy] | |||
range carbon total dose | 18-45 | ||
range proton total dose | 10-57.2 | ||
range photon total dose | 50 | ||
[mm] | |||
Tumor diameter before RT | 29.7 | ||
Tumor diameter at first follow-up | 27.1 | ||
Tumor diameter at second follow-up | 24.9 | ||
[n] | [%] | ||
relapse meningioma | 0 | 0 | |
relapse glioma WHO ° II | 0 | 0 | |
relapse glioma WHO ° III/° III | 9 | 42.3 |